These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24402311)

  • 1. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.
    Metz R; Smith C; DuHadaway JB; Chandler P; Baban B; Merlo LM; Pigott E; Keough MP; Rust S; Mellor AL; Mandik-Nayak L; Muller AJ; Prendergast GC
    Int Immunol; 2014 Jul; 26(7):357-67. PubMed ID: 24402311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.
    Merlo LMF; DuHadaway JB; Montgomery JD; Peng WD; Murray PJ; Prendergast GC; Caton AJ; Muller AJ; Mandik-Nayak L
    Front Immunol; 2020; 11():1861. PubMed ID: 32973768
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Fujii K; Yamamoto Y; Mizutani Y; Saito K; Seishima M
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752186
    [No Abstract]   [Full Text] [Related]  

  • 4. The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.
    Trabanelli S; Očadlíková D; Ciciarello M; Salvestrini V; Lecciso M; Jandus C; Metz R; Evangelisti C; Laury-Kleintop L; Romero P; Prendergast GC; Curti A; Lemoli RM
    J Immunol; 2014 Feb; 192(3):1231-40. PubMed ID: 24391212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
    Li Q; Harden JL; Anderson CD; Egilmez NK
    J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation.
    Qian F; Liao J; Villella J; Edwards R; Kalinski P; Lele S; Shrikant P; Odunsi K
    Cancer Immunol Immunother; 2012 Nov; 61(11):2013-20. PubMed ID: 22527253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.
    Merlo LMF; Pigott E; DuHadaway JB; Grabler S; Metz R; Prendergast GC; Mandik-Nayak L
    J Immunol; 2014 Mar; 192(5):2082-2090. PubMed ID: 24489090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDO2 in Immunomodulation and Autoimmune Disease.
    Prendergast GC; Metz R; Muller AJ; Merlo LM; Mandik-Nayak L
    Front Immunol; 2014; 5():585. PubMed ID: 25477879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
    Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
    Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the kynurenine pathway in Indoleamine 2, 3 dioxygenase deficient mice with inflammatory arthritis.
    Kolodziej L
    Transgenic Res; 2013 Oct; 22(5):1049-54. PubMed ID: 23417792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of IDO1 and IDO2 on the B Cell Immune Response.
    Merlo LMF; Peng W; Mandik-Nayak L
    Front Immunol; 2022; 13():886225. PubMed ID: 35493480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes.
    Pallotta MT; Orabona C; Bianchi R; Vacca C; Fallarino F; Belladonna ML; Volpi C; Mondanelli G; Gargaro M; Allegrucci M; Talesa VN; Puccetti P; Grohmann U
    J Cell Mol Med; 2014 Oct; 18(10):2082-91. PubMed ID: 25215657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
    Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
    Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus.
    Brooks AK; Lawson MA; Smith RA; Janda TM; Kelley KW; McCusker RH
    J Neuroinflammation; 2016 May; 13(1):98. PubMed ID: 27142940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling.
    Yamamoto Y; Yamasuge W; Imai S; Kunisawa K; Hoshi M; Fujigaki H; Mouri A; Nabeshima T; Saito K
    Sci Rep; 2018 Oct; 8(1):15917. PubMed ID: 30374077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
    Muller AJ; Sharma MD; Chandler PR; Duhadaway JB; Everhart ME; Johnson BA; Kahler DJ; Pihkala J; Soler AP; Munn DH; Prendergast GC; Mellor AL
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17073-8. PubMed ID: 18952840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.
    Liu X; Shin N; Koblish HK; Yang G; Wang Q; Wang K; Leffet L; Hansbury MJ; Thomas B; Rupar M; Waeltz P; Bowman KJ; Polam P; Sparks RB; Yue EW; Li Y; Wynn R; Fridman JS; Burn TC; Combs AP; Newton RC; Scherle PA
    Blood; 2010 Apr; 115(17):3520-30. PubMed ID: 20197554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.